Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
Mesoglycan (Prisma ) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

The objective of the study is to demonstrate the superiority of the mesoglycan (Prisma), compared to placebo, in reducing the incidence of thromboembolic complications (relapse / extension of superficial venous thrombosis (SVT), deep venous thrombosis (DVT), pulmonary embolism (PE)) in patients who have completed the cycle of therapy of the …

  • 9 views
  • 25 Mar, 2021
  • 1 location
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

The purpose of this study is to test the effectiveness of the experimental drug, 177Lu-J591 in combination with ketoconazole and hydrocortisone against prostate cancer.

diphosphonates
testosterone
monoclonal antibodies
adenocarcinoma of prostate
ketoconazole
  • 139 views
  • 12 Mar, 2021
  • 14 locations
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia

The purpose of this study is to evaluate the safety and tolerability of Palbociclib in combination with investigational (experimental) drug, CPX-351 and evaluate the efficacy of Palbociclib in

secondary acute myeloid leukemia
gilbert's syndrome
cancer
daunorubicin
cytarabine
  • 2 views
  • 28 Apr, 2021
  • 2 locations
Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

This is a Phase I/Ib study whose purpose is to find out if combining an experimental drug called binimetinib with pembrolizumab is beneficial in people who have advanced non-small cell lung

  • 7 views
  • 11 Apr, 2021
  • 1 location
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

This study will compare the effects of treatment with nivolumab alone versus those of nivolumab plus the experimental drug BMS-986205. Adding BMS-986208 to nivolumab could shrink the cancer or

neutrophil count
papillary serous adenocarcinoma
x-rays
hormone therapy
systemic chemotherapy
  • 1 views
  • 26 Jan, 2021
  • 7 locations
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation

carcinoma
neck cancer
squamous cell carcinoma of the oral cavity
head and neck cancer
squamous cell carcinoma
  • 0 views
  • 18 Feb, 2021
  • 7 locations
KRDI in Transplant-Eligible MM

This research study is testing the efficacy of an experimental drug combination for people with newly diagnosed multiple myeloma that are eligible for a stem cell transplant. The names of

neutrophil count
granulocyte colony stimulating factor
immunoglobulins
kappa light chain
progressive disease
  • 0 views
  • 26 Jan, 2021
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction

understand how blood pressure affects your level of pain. This study is not testing an experimental drug.

  • 0 views
  • 02 May, 2021
  • 1 location
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

This study evaluates the intratumoral administration of escalating doses of a novel, experimental drug, INT230-6. The study is being conducted in patients with several types of refractory

carcinoma
neutrophil count
gilbert's syndrome
soft tissue sarcoma
squamous cell carcinoma
  • 720 views
  • 17 Apr, 2021
  • 7 locations
Ibrutinib + Venetoclax in Untreated WM

MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies. The names of the study drugs involved in this study are: Venetoclax

bone marrow procedure
neutrophil count
ibrutinib
measurable disease
cancer
  • 0 views
  • 27 Jan, 2021
  • 1 location